1921
Volume 96, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract

Human immunodeficiency virus (HIV) and dengue coinfection has not been extensively studied. We report herein a case of dengue serotype 1 infection in an HIV-1-positive patient coinfected with hepatitis B virus (HBV) in Colima State, Mexico. CD4 cells and HIV-1 viremia remained at normal levels, and no severe complications were observed during this multiple viral infection. The alanine transaminase and aspartate transaminase values were elevated before and during dengue infection. Surprisingly, these parameters were significantly reduced 2 months later. Because of the lack of evidence regarding this multiple viral interaction, further research is required to understand the biologic and clinical course of dengue infection in HIV-1/HBV coinfected patients, especially in tropical regions where dengue virus transmission is highly active.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.16-0477
2017-01-11
2018-12-19
Loading full text...

Full text loading...

/deliver/fulltext/14761645/96/1/122.html?itemId=/content/journals/10.4269/ajtmh.16-0477&mimeType=html&fmt=ahah

References

  1. Sun HY, Sheng WH, Tsai MS, Lee KY, Chang SY, Hung CC, , 2014. Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review. World J Gastroenterol 20: 1459814614.[Crossref] [Google Scholar]
  2. Huang AJ, Núñez M, , 2015. Outcomes in HIV/HBV-coinfected patients in the tenofovir era are greatly affected by immune suppression. J Int Assoc Provid AIDS Care 14: 360368.[Crossref] [Google Scholar]
  3. Alemu A, Shiferaw Y, Addis Z, Mathewos B, Birhan W, , 2013. Effect of malaria on HIV/AIDS transmission and progression. Parasit Vectors 6: 18.[Crossref] [Google Scholar]
  4. Morgado MG, Barcellos C, Pina MF, Bastos FI, , 2000. Human immunodeficiency virus/acquired immunodeficiency syndrome and tropical diseases: a Brazilian perspective. Mem Inst Oswaldo Cruz 95 (Suppl 1): 145151.[Crossref] [Google Scholar]
  5. Harms G, Feldmeier H, , 2005. The impact of HIV infection on tropical diseases. Infect Dis Clin North Am 19: 121135.[Crossref] [Google Scholar]
  6. World Health Organization, 2014. Dengue and Severe Dengue [Internet]. Updated March 2014. Available at: http://www.who.int/mediacentre/factsheets/fs117/en/. [Google Scholar]
  7. Weaver SC, Vasilakis N, , 2009. Molecular evolution of dengue viruses: contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease. Infect Genet Evol 9: 523540.[Crossref] [Google Scholar]
  8. Watt G, Kantipong P, Jongsakul K, , 2003. Decrease in human immunodeficiency virus type 1 load during acute dengue fever. Clin Infect Dis 36: 10671069.[Crossref] [Google Scholar]
  9. Gonzalez D, Limonta D, Bandera JF, Perez J, Kouri G, Guzman MG, , 2009. Dual infection with dengue virus 3 and human immunodeficiency virus 1 in Havana, Cuba. J Infect Dev Ctries 3: 318320. [Google Scholar]
  10. Siong WC, Ching TH, Jong GC, Pang CS, Vernon LJ, Sin LY, , 2008. Dengue infections in HIV patients. Southeast Asian J Trop Med Public 39: 260265. [Google Scholar]
  11. Mendes W da S, Branco M dos R, Medeiros MN, , 2006. Clinical case report: dengue hemorrhagic fever in a patient with acquired immunodeficiency syndrome. Am J Trop Med Hyg 74: 905907. [Google Scholar]
  12. Pang J, Thein TL, Lye DC, Leo YS, , 2015. Differential clinical outcome of dengue infection among patients with and without HIV infection: a matched case-control study. Am J Trop Med Hyg 92: 11561162.[Crossref] [Google Scholar]
  13. Torrentes-Carvalho A, Hottz ED, Marinho CF, da Silva JB, de Oliveira Pinto LM, Fialho LG, Bozza FA, Cunha RV, Damasco PV, Kubelka CF, de Azeredo EL, , 2016. Characterization of clinical and immunological features in patients coinfected with dengue virus and HIV. Clin Immunol 164: 95105.[Crossref] [Google Scholar]
  14. Soriano V, Poveda E, Vispo E, Barreiro P, , 2013. Hepatitis B in HIV-infected patients. Clin Liver Dis 17: 489501.[Crossref] [Google Scholar]
  15. Samanta J, Sharma V, , 2015. Dengue and its effects on liver. World J Clin Cases 3: 125131.[Crossref] [Google Scholar]
  16. Agarwal MP, Giri S, Sharma V, Roy U, Gharsangi K, , 2011. Dengue causing fulminant hepatitis in a hepatitis B virus carrier. Biosci Trends 5: 4445.[Crossref] [Google Scholar]
  17. Tang Y, Kou Z, Tang X, Zhang F, Yao X, Liu S, Jin X, , 2008. Unique impacts of HBV co-infection on clinical and laboratory findings in a recent dengue outbreak in China. Am J Trop Med Hyg 79: 154158. [Google Scholar]
  18. Wan Z, Xie G, Wu Y, Liu F, Xin S, You S, Liu H, Li C, Li D, , 2016. Cytokines elevated in patients with HBV-related acute-on-chronic liver failure promote NK cell mediated cytotoxicity through TRAIL. Dig Liver Dis 48: 528535.[Crossref] [Google Scholar]
  19. Law WP, Duncombe CJ, Mahanontharit A, Boyd MA, Ruxrungtham K, Lange JM, Phanuphak P, Cooper DA, Dore GJ, , 2004. Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort. AIDS 18: 11691177.[Crossref] [Google Scholar]
  20. Stylianou E, Aukrust P, Kvale D, Müller F, Frøland SS, , 1999. IL-10 in HIV infection: increasing serum IL-10 levels with disease progression—down-regulatory effect of potent anti-retroviral therapy. Clin Exp Immunol 116: 115120.[Crossref] [Google Scholar]
  21. Aukrust P, Müller F, Lien E, Nordoy I, Liabakk NB, Kvale D, Espevik T, Frøland SS, , 1999. Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure. J Infect Dis 179: 7482.[Crossref] [Google Scholar]
  22. Malavige GN, Huang LC, Salimi M, Gomes L, Jayaratne SD, Ogg GS, , 2012. Cellular and cytokine correlates of severe dengue infection. PLoS One 7: e50387.[Crossref] [Google Scholar]
  23. McLinden JH, Stapleton JT, Chang Q, Xiang J, , 2008. Expression of the dengue virus type 2 NS5 protein in a CD4+ T cell line inhibits HIV replication. J Infect Dis 198: 860863.[Crossref] [Google Scholar]
  24. Xiang J, McLinden JH, Rydze RA, Chang Q, Kaufman TM, Klinzman D, Stapleton JT, , 2009. Viruses within the Flaviviridae decrease CD4 expression and inhibit HIV replication in human CD4+ cells. J Immunol 183: 78607869.[Crossref] [Google Scholar]
  25. López-Lemus UA, Vásquez C, Vázquez-Campuzano R, Valle-Reyes S, Guzmán-Bracho C, Araiza-Garaygordobil D, Rebolledo-Prudencio N, Delgado-Enciso I, Espinoza-Gómez F, , 2014. Dengue virus serotype 1 non-structural protein NS5 expression interferes with HIV replication in a CD4+ T-cell line. Am J Trop Med Hyg 90: 418421.[Crossref] [Google Scholar]
  26. De Clercq E, Schols D, , 2001. Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists. Antivir Chem Chemother 12 (Suppl 1): 1931. [Google Scholar]
  27. Diepolder HM, Gerlach JT, Zachoval R, Hoffmann RM, Jung MC, Wierenga EA, Scholz S, Santantonio T, Houghton M, Southwood S, Sette A, Pape GR, , 1997. Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol 71: 60116019. [Google Scholar]
  28. González R, Ataíde R, Naniche D, Menéndez C, Mayor A, , 2012. HIV and malaria interactions: where do we stand? Expert Rev Anti Infect Ther 10: 153165.[Crossref] [Google Scholar]
  29. Rabello A, Orsini M, Disch J, , 2003. Leishmania/HIV co-infection in Brazil: an appraisal. Ann Trop Med Parasitol 97 (Suppl 1): 1728.[Crossref] [Google Scholar]
  30. Rocha A, de Meneses AC, da Silva AM, Ferreira MS, Nishioka SA, Burgarelli MK, Almeida E, Turcato Júnior G, Metze K, Lopes ER, , 1994. Pathology of patients with Chagas disease and acquired immunodeficiency syndrome. Am J Trop Med Hyg 50: 261268. [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.16-0477
Loading
/content/journals/10.4269/ajtmh.16-0477
Loading

Data & Media loading...

  • Received : 14 Jun 2016
  • Accepted : 27 Sep 2016

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error